Patents by Inventor Mauro Castiglioni

Mauro Castiglioni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11786466
    Abstract: The present invention provides a liposomal topical formulation or a liposomal topical formulation base having barrier-forming siliconic components, methods for making the same, and methods for using the same in the treatment of dermatological diseases and conditions, including male pattern baldness.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: October 17, 2023
    Assignee: XYON Health Inc.
    Inventors: Victor Hasson, Mauro Castiglioni
  • Publication number: 20230181430
    Abstract: The present disclosure provides a liposomal topical formulation comprising dutasteride having barrier-forming siliconic components, methods for making the same, and methods for using the same in the treatment of dermatological diseases and conditions, including male pattern baldness.
    Type: Application
    Filed: May 3, 2021
    Publication date: June 15, 2023
    Applicant: XYON Health Inc.
    Inventors: Victor Hasson, Mauro Castiglioni
  • Publication number: 20200383916
    Abstract: The present invention provides a liposomal topical formulation or a liposomal topical formulation base having barrier-forming siliconic components, methods for making the same, and methods for using the same in the treatment of dermatological diseases and conditions, including male pattern baldness.
    Type: Application
    Filed: October 26, 2018
    Publication date: December 10, 2020
    Applicant: TopiRX Therapeutics Inc.
    Inventors: Victor HASSON, Mauro CASTIGLIONI
  • Publication number: 20050226899
    Abstract: The present invention relates to a cosmetic composition, particularly in the form of a self-curing mask, containing trans-retinoic acid together with cosmetically acceptable excipients, wherein said trans-retinoic acid is comprised in amounts up to 20% by weight with respect to said excipients. The cosmetic composition of the invention may be used as an “anti-ageing” treatment.
    Type: Application
    Filed: April 8, 2004
    Publication date: October 13, 2005
    Inventors: Mauro Castiglioni, Riccardo Forte